Article / Jun 01, 2015
Developing an Orally Inhaled Dry Powder Formulation
Pharmaceutical Technology, June 2015
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Pharmaceutical Technology, June 2015
Manufacturing Chemist, 27 July 2015
Hovione Expands Particle Design Solutions to Solve Bioavailability and Other Drug Delivery Challenges
Hovione Announces the Appointment of Conrad Winters, PhD as Drug Product Development Director
Drug Development and Delivery, October 2012
The 12th successful inspection in 18 months
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)